A Superior Anesthetic Technique for the Cesarean Section From a Hemodynamic Perspective.

NCT04989270 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2021-08-04

No results posted yet for this study

Summary

Cesarean section operations are increasing in rates worldwide. A proper anesthetic technique is required to maintain the safety of both the mother and the fetus. This study examines the adverse hemodynamic effects associated with general and regional anesthesia and proposes a superior technique from the hemodynamic perspective.

A retrospective cohort study with a five-year study period was conducted on patients who underwent cesarean section with general anesthesia (GA) and regional anesthesia (RA) after obtaining ethical committee approval. Data (hypotension, bradycardia, and blood loss) was collected from hospital information system records of the patients who underwent cesarean section from January 2015 to December 2019. The significance of the variables was determined using the Chi-square test.

A total of 2500 patients were studied. 1379 patients underwent cesarean section with RA meanwhile 1121 patients with GA.

Conditions

  • Obstetric Anaesthesia With Cardiac Complications

Interventions

PROCEDURE

General Anesthesia

General anesthesia with intubation, ventilation, intravenous and inhalational anesthetics, opioids and muscle paralysis

PROCEDURE

Regional Anesthesia

Spinal Anesthesia, Epidural Anesthesia

Sponsors & Collaborators

  • Sultan Qaboos University

    lead OTHER

Principal Investigators

  • Jyoti Burad, MD, EDIC · Sultan Qaboos University Hospital

Eligibility

Min Age
17 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-07
Primary Completion
2021-03-31
Completion
2021-05-15

Countries

  • Oman

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04989270 on ClinicalTrials.gov